Bristol-Myers Squibb received federal approval of its Sustiva drug for children with HIV as young as 3 months. The approval allows the capsule to be opened and added to food or a beverage for patients who cannot swallow capsules or tablets.
Pediatric HIV drug gains FDA approval
SmartBrief Job Listings for Health Care
|Account Management and Product Development Specialist||
Sharp Health Plan
|San Diego, CA|
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.